PT Enseval Putera Megatrading Tbk. (EPMT.JK)
IDR 2360.0
(0.0%)
IDR 2360.0
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 2913.35 Billion IDR | -1.71% |
| 2022 | 2963.99 Billion IDR | 5.66% |
| 2021 | 2805.13 Billion IDR | 14.09% |
| 2020 | 2458.63 Billion IDR | 0.15% |
| 2019 | 2454.92 Billion IDR | 2.42% |
| 2018 | 2397 Billion IDR | 12.31% |
| 2017 | 2134.19 Billion IDR | -1.98% |
| 2016 | 2177.24 Billion IDR | 3.19% |
| 2015 | 2109.84 Billion IDR | 9.33% |
| 2014 | 1929.77 Billion IDR | 9.44% |
| 2013 | 1763.29 Billion IDR | 22.76% |
| 2012 | 1436.41 Billion IDR | 18.78% |
| 2011 | 1209.34 Billion IDR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | 701.17 Billion IDR | 16.52% |
| 2024 Q1 | 794.77 Billion IDR | 7.83% |
| 2024 Q2 | 639.85 Billion IDR | -19.49% |
| 2023 Q3 | 752.44 Billion IDR | 20.97% |
| 2023 FY | 2913.35 Billion IDR | -1.71% |
| 2023 Q1 | 801.87 Billion IDR | 12.46% |
| 2023 Q2 | 621.98 Billion IDR | -22.43% |
| 2023 Q4 | 737.05 Billion IDR | -2.05% |
| 2022 Q1 | 789.23 Billion IDR | 16.6% |
| 2022 FY | 2963.99 Billion IDR | 5.66% |
| 2022 Q4 | 713.04 Billion IDR | -9.06% |
| 2022 Q3 | 784.12 Billion IDR | 15.72% |
| 2022 Q2 | 677.59 Billion IDR | -14.15% |
| 2021 Q3 | 739.72 Billion IDR | 11.76% |
| 2021 Q2 | 661.88 Billion IDR | -8.91% |
| 2021 Q4 | 676.86 Billion IDR | -8.5% |
| 2021 Q1 | 726.66 Billion IDR | 7.99% |
| 2021 FY | 2805.13 Billion IDR | 14.09% |
| 2020 Q1 | 644.63 Billion IDR | 4.73% |
| 2020 FY | 2458.63 Billion IDR | 0.15% |
| 2020 Q2 | 599.92 Billion IDR | -6.94% |
| 2020 Q3 | 541.16 Billion IDR | -9.79% |
| 2020 Q4 | 672.89 Billion IDR | 24.34% |
| 2019 FY | 2454.92 Billion IDR | 2.42% |
| 2019 Q3 | 626.11 Billion IDR | -1.67% |
| 2019 Q4 | 615.51 Billion IDR | -1.69% |
| 2019 Q1 | 576.57 Billion IDR | -8.29% |
| 2019 Q2 | 636.71 Billion IDR | 10.43% |
| 2018 Q2 | 593.79 Billion IDR | 8.5% |
| 2018 Q1 | 547.29 Billion IDR | -11.79% |
| 2018 Q4 | 628.71 Billion IDR | 0.24% |
| 2018 FY | 2397 Billion IDR | 12.31% |
| 2018 Q3 | 627.19 Billion IDR | 5.62% |
| 2017 Q2 | 549.59 Billion IDR | 15.27% |
| 2017 FY | 2134.19 Billion IDR | -1.98% |
| 2017 Q4 | 620.44 Billion IDR | 27.31% |
| 2017 Q3 | 487.34 Billion IDR | -11.33% |
| 2017 Q1 | 476.79 Billion IDR | -24.58% |
| 2016 Q4 | 632.21 Billion IDR | 31.05% |
| 2016 FY | 2177.24 Billion IDR | 3.19% |
| 2016 Q3 | 482.41 Billion IDR | -12.03% |
| 2016 Q2 | 548.38 Billion IDR | 6.64% |
| 2016 Q1 | 514.22 Billion IDR | -12.34% |
| 2015 FY | 2109.84 Billion IDR | 9.33% |
| 2015 Q4 | 586.59 Billion IDR | 4.54% |
| 2015 Q3 | 561.11 Billion IDR | 10.91% |
| 2015 Q2 | 505.92 Billion IDR | 10.9% |
| 2015 Q1 | 456.21 Billion IDR | -14.28% |
| 2014 FY | 1929.77 Billion IDR | 9.44% |
| 2014 Q4 | 532.22 Billion IDR | 8.28% |
| 2014 Q3 | 491.53 Billion IDR | 2.6% |
| 2014 Q2 | 479.09 Billion IDR | 12.22% |
| 2014 Q1 | 426.92 Billion IDR | -19.92% |
| 2013 Q4 | 533.13 Billion IDR | 18.96% |
| 2013 FY | 1763.29 Billion IDR | 22.76% |
| 2013 Q1 | 365.66 Billion IDR | -20.87% |
| 2013 Q2 | 416.35 Billion IDR | 13.86% |
| 2013 Q3 | 448.14 Billion IDR | 7.64% |
| 2012 Q1 | 308.88 Billion IDR | 0.0% |
| 2012 FY | 1436.41 Billion IDR | 18.78% |
| 2012 Q3 | 347.3 Billion IDR | 9.18% |
| 2012 Q4 | 462.12 Billion IDR | 33.06% |
| 2012 Q2 | 318.1 Billion IDR | 2.99% |
| 2011 FY | 1209.34 Billion IDR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| PT Itama Ranoraya Tbk | 127.06 Billion IDR | -2192.888% |
| PT Kimia Farma (Persero) Tbk | 2780.27 Billion IDR | -4.787% |
| PT Millennium Pharmacon International Tbk | 273.37 Billion IDR | -965.699% |
| PT Soho Global Health Tbk | 1257.75 Billion IDR | -131.632% |